Jump to start of content

Coronavirus Updates Expand/Collapse the ABIM alert.

At ABIM we are actively monitoring the ongoing spread of coronavirus (COVID-19) and will post regular updates about any changes to scheduled assessments.
Scheduled for an assessment this year? ABIM is working with Pearson VUE to ensure your safety throughout your exam day. Learn more about what to expect at test centers.
Please follow the United States Centers for Disease Control and Prevention (CDC) for the most up-to-date information on the virus.

Breadcrumb trail:

Gastroenterology Board

Expand All | Collapse All

Jane E. Onken, MD, Chair

Jane E. Onken, MDDr. Onken is an Associate Professor of Medicine, Division of Gastroenterology at Duke University Medical Center. She is Director of the Inflammatory Bowel Disease Clinic at Duke and on faculty at the Duke Clinical Research Institute. She is board certified in Gastroenterology.

Dr. Onken is Chair of the American Board of Internal Medicine (ABIM) Gastroenterology Board and a member of the ABIM Council. She recently completed a three-year term as Chair of the Education and Training Committee of the American Gastroenterological Association (AGA). During that term, she served on the AGA's Leadership Cabinet, the Maintenance of Certification Task Force, and the Board of the Academy of Educators. She has chaired the AGA Training Subcommittee and been a member of the Graduate Training Examination Subcommittee. In 2013, she was selected to join the multi-society Oversight Working Network Committee, a group that designed the Entrustable Professional Activities currently in use by training programs in Gastroenterology. At Duke, she was recently elected for a fourth term to the University's Academic Council and has served on the Executive Committee of the Academic Council. Dr. Onken is a former program director for the Duke Gastroenterology Fellowship program. She is a member of the Leadership Board of the Triangle Chapter of the Crohn's and Colitis Foundation of America (CCFA) and is a recipient of the CCFA Premier Physician Award.

Dr. Onken received her undergraduate degree from Smith College and attended the George Washington University School of Medicine. She completed her house staff training in internal medicine at Duke University, followed by fellowship training in gastroenterology. She received a master's degree in health sciences from Duke in 2005.

As of May 2020, Dr. Onken reported the following external relationships:

Funding for clinical trial expenses, staff and salary support, paid to Duke University, from the following companies:

  • Boehringer Ingelheim, for a phase II/III clinical trial in patients with moderate to severe ulcerative colitis.
  • Janssen, for phase I clinical trial of ustekinumab in Crohn's disease.
  • Seres, for a clinical trial investigating fecal replacement for patients with mild-to-moderate ulcerative colitis.

Dr. Onken serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • American Gastroenterological Association, Special Section Editor of Education and Training, receiving honoraria.
  • Crohn’s and Colitis Foundation, Triangle Patient Education Day Planning Committee Member and Speaker, without compensation.

Nikhil Bhargava, DO

Nikhil BhargavaDr. Bhargava is a partner at Digestive Disease Consultants in Bourbonnais, IL. He is dually board certified by the American Board of Internal Medicine in Gastroenterology (2018) and Internal Medicine (2015).

His professional appointments include Clinical Assistant Professor of Medicine at Midwestern University in Downers Grove, IL and Program Director for the Gastroenterology Fellowship at Riverside Medical Center. He is actively involved in clinical research and trains medical students, residents and fellows.

He is a fellow of the American College of Gastroenterology, the American Gastroenterology Association the American Society of Gastrointestinal Endoscopy. He is also a member of the Illinois State Medical Society and the Kankakee County Medical Society. He also serves on the Medical Advisory Committee for the Great Lakes Division of the American for Liver Foundation.

Dr. Bhargava attended medical school at the Chicago College of Osteopathic Medicine in Downers Grove, IL. He then completed internal medicine residency at McGaw Medical Center at Northwestern University in Evanston, IL. He finished his medical training with the completion of gastroenterology fellowship at the University of Wisconsin/Aurora Sinai Medical Center, Milwaukee Campus.

As of September 2019, Dr. Bhargava reported the following external relationships:

Preclinical research with funding for salary support from the following companies:

  • TrialSpark, Inc.

Dr. Bhargava serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Riverside Medical Center, leading quarterly leadership retreat with administrators and physicians, and administering student rotations and lectures, receiving honoraria.

Kenneth R. DeVault, MD

Kenneth R. DeVault, MDDr. DeVault is Professor and Chair of the Department of Medicine at Mayo Clinic Florida. He is a member of the Executive Operating Team of Mayo Clinic in Florida. Dr. DeVault is board certified in Internal Medicine and Gastroenterology.

Prior to becoming Chair of Medicine, Dr. DeVault was Chair of the Division of Gastroenterology and Hepatology at the Mayo Clinic Florida from 2005-2010. He is a member of the American Board of Internal Medicine Gastroenterology Board. Dr. DeVault is a Fellow of and past president of the American College of Gastroenterology. He is also a member of the American Gastroenterological Association, American Society for Gastrointestinal Endoscopy and a fellow of the American College of Physicians.

Dr. DeVault conducts research on disorders affecting all aspects of the esophagus and has written more than 250 book chapters, abstracts, editorials and original articles on subjects ranging from treatment of GERD, dysphagia, esophagitis and Barrett's esophagus to laparoscopic anti-reflux surgery and managed care issues in the treatment of GERD. He also has interest in gastrointestinal health in the third world, improving professionalism in both trainees and practicing physicians and in the development of a diverse and effective health care work force.

He received his undergraduate degree from the University of Tennessee and his medical degree from the Bowman Gray School of Medicine at Wake Forest University. He completed his internship and residency in internal medicine at Vanderbilt University and completed a combined clinical and research fellowship at Jefferson Medical College.

As of April 2019, Dr. Devault reported no external relationships.

Hannah M. Herrington, MPH, CPH, CHES

Hannah M. Herrington, MPH, CPH, CHESMs. Herrington is currently a Health Communication Manager, consulting with government agencies and health industry clients on how to best engage people, patients, and caregivers in their health care, utilizing health literacy and clear communication best practices.

She has been working in the healthcare field for over a decade, from humanitarian organizations and insurance companies to corporate wellness firms. Ms. Herrington serves as a member of the American Board of Internal Medicine Gastroenterology Board. She was previously the Senior Manager of Patient Communications at the American Gastroenterological Association, setting up their first-ever patient engagement initiative, drafting and overseeing their 25-topic gastrointestinal (GI) patient education digital library.

Ms. Herrington has a personal connection to GI health as a long-time patient herself. She has had Crohn's disease for over 20 years, diagnosed as a teen. She's spent time educating herself about IBD research and new treatments, and staying involved in inflammatory bowel disease (IBD) advocacy and patient support organizations.

She received her master of public health degree, with a concentration in behavioral science and health education, from Rollins School of Public Health at Emory University in Atlanta, Georgia. Ms. Herrington is also certified in Public Health and a Certified Health Education Specialist.

As of March 2020, Ms. Herrington reported the following external relationship:

Ms. Herrington reported health literacy and health communications consulting to ensure consumer understanding and general usability for websites or patient portals.

Scharles Konadu, MD

Scharles KonaduDr. Konadu is a general gastroenterologist and consultant for the multi-specialty group Huguley Medical Associates in Burleson Texas. Prior to her current position she served as faculty and consultant in gastroenterology with Duke University Medical Center in Durham, North Carolina and Duke Raleigh Hospital in Raleigh, North Carolina. She is board-certified in both Internal Medicine and Gastroenterology.

She serves as a member of the American Board of Internal Medicine Gastroenterology Board and serves on the American Gastroenterology Association's international committee. She also serves on the board and as secretary for the West African Institute for Liver and Digestive Diseases. She was recently honored by her colleagues as Tarrant County Top Doctor in Gastroenterology 2020.

Her main clinical interests are in colon cancer prevention and irritable bowel syndrome. She houses a passion for global health and some of her most esteemed experiences include her time educating and observing in Beijing, China and Ghana, West Africa.

She received her bachelor's degree from the University of Texas at Austin and obtained her medical degree from The University of Texas Southwestern Medical Center in Dallas, Texas. She completed both her residency and fellowship at Duke University Medical Center in Durham North Carolina.

As of September 2019, Dr. Konadu reported the following external relationships:

Dr. Konadu serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • American Gastroenterological Association, International Committee Member, without compensation.

Nancy S. Reau, MD

Nancy S. Reau, MDDr. Reau, who is board certified in internal medicine, gastroenterology, and transplant hepatology, is currently Associate Director of Solid Organ Transplantation and Section Chief of Hepatology at Rush University Medical Center.

She previously served as Assistant Professor of Medicine at Rush University in Chicago from 2002 to 2005. She became an Associate Professor of Medicine in 2010, Medical Director of Hepatology Clinical and Translational Research in 2015 and then joined Rush University Medical Center in 2015.

Dr. Reau's research interest is in viral hepatitis, both in drug development as well as utilization. She is currently a member of the American Board of Internal Medicine Gastroenterology Board, the American Association for the Study of Liver Diseases (AASLD) steering committee for the hepatitis C special interest group, and the AASLD/IDSA Practice Guidelines for hepatitis C. She served as Chair of the AASLD public policy committee. Additionally, Dr. Reau is a member of the American College of Gastroenterology women's training committee. She has been a member of the national board of directors of the American Liver Foundation (ALF) and served as the president of the Illinois chapter. She is currently co-Chair of the National ALF Medical Advisory Committee and serves on multiple advisory boards including Medscape and Medivo.

Dr. Reau received her bachelor's degree at Oberlin College in Oberlin, Ohio. She received her medical degree, cum laude, and completed a medicine residency and gastroenterology fellowship at The Ohio State University in Columbus, Ohio. She went to The Johns Hopkins Medical Center in Baltimore, MD, where she did her advanced transplant hepatology fellowship in 2001.

As of October 2019, Dr. Reau reported the following external relationships:

Funding for clinical trial expenses and staff, paid to the University of Chicago, from the following companies:

  • GenFit, for NASH study.
  • TARGET, for an observational trial on hepatitis C.

Service on a research-related expert panel or advisory board for the following companies, with compensation as listed:

  • Abbott, advising on development of hepatitis B and hepatitis C, receiving honoraria.
  • AbbVie, serving on a national advisory board for clinical development in hepatitis C, receiving travel reimbursement and honoraria.
  • Gilead, serving on a national advisory board for clinical development in hepatitis C, receiving travel reimbursement and honoraria.
  • Merck, advising on national and global development in hepatitis C, receiving travel reimbursement and honoraria.
  • Intercept, serving on an advisory board, receiving travel reimbursement and honoraria.

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following company, with compensation as listed:

  • Abbott, consulting on viral hepatitis education, receiving honoraria.

Industry-supported continuing medical education supported by the following, with compensation for travel expenses and honoraria:

Dr. Reau develops educational content for continuing medical education on hepatitis C and provides an update to the American Association for the Study of Liver Disease for Clinical Care Options, receiving honoraria. Clinical Care Options is a medical education company that develops educational content and decision support tools.

Dr. Reau develops educational content for continuing medical education on hepatitis C receiving honoraria from the Chronic Liver Disease Foundation, which receives support from educational grants from multiple pharmaceutical companies

Dr. Reau serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American Association for the Study of Liver Disease, Member of the Steering Committee for the Hepatitis C Special Interest Group, Editor-in-Chief of Clinical Liver Disease, receiving honoraria.
  • American College of Gastroenterology, Continuing Medical Education at courses, receiving honoraria and reimbursement for travel expenses.

Richard K. Sterling, MD

Dr. Sterling is currently a Virginia Commonwealth University (VCU) Hepatology Professor of Medicine in the Divisions of Gastroenterology, Hepatology, and Nutrition and Infectious Diseases, Section Chief of Hepatology and Medical Director of Viral Hepatitis and Transplant Hepatology Fellowship Director. He is board certified in Internal Medicine, Gastroenterology, and Liver Transplantation, and serves as a member of the American Board of Internal Medicine Gastroenterology Board. His research interest is in HIV-liver disease which is supported by several NIH grants. He is site Principle Investigator (PI) for the Hepatitis B Research Network and was PI for the HALT-C trial. Other research interests include biomarkers for non-invasive assessments of liver disease, viral hepatitis, and liver transplantation.

He has published over 200 papers and serves on several prominent committees in the American Gastroenterological Association (AGA), the American Association for the Study of Liver Diseases (AASLD), and the American College of Gastroenterology (ACG) and has served on study sections of the NIH. He is on several AASLD committees including the AASLD Transplant Hepatology Pilot Steering Committee, the Development Committee, the Education Committee, as well as on the Liver-Biliary Council of the AGA and has served as the ACG Governor for Virginia for six years.

Dr. Sterling received his bachelor’s degree in chemistry and natural science from Muhlenberg College (1982), a master’s degree in biochemistry from the University of Texas in Austin (1984), a medical degree from Jefferson Medical College in Philadelphia (1988) and a master’s of science in biostatistics and clinical research from VCU (2007). After completing an internship and residency in internal medicine at Virginia Commonwealth University (VCU), he went on to complete a fellowship in gastroenterology, hepatology, and nutrition at VCU, which includes specialized training in transplant hepatology in 1994.

As of July 2019, Dr. Sterling reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Virginia Commonwealth University, from the following companies:

  • Abbott, for a Hepatitis B clinical trial.
  • AbbVie, for two Hepatitis C clinical trials.
  • Gilead, for two Hepatitis C clinical trials.
  • Roche, providing test kits for hepatitis B testing in support for an R01 research grant.

Service on data and safety monitoring boards for the following companies, with compensation for travel expenses and honoraria:

  • Baxter, for a trial using adenovirus to treat hemophilia.
  • Pfizer, for a HIV drug trial.

Laura D. Wingate, BA

Laura D. Wingate, BAMs. Wingate is Senior Vice President, Education, Support, & Advocacy for the Crohn's & Colitis Foundation, where she oversees patient and professional education, state and federal advocacy, and support programming for the Foundation. She works in conjunction with the Crohn's & Colitis Foundation National Scientific Advisory Committees and numerous patient volunteers on developing all programs and resources.

Prior to this, Ms. Wingate was Director of Operations for Clown Care & Vaudeville Caravan Programs, where she worked for eight years in providing professional entertainers to pediatric and geriatric centers across the United States. She began her career at Memorial Sloan Kettering Cancer Center, where she advised and implemented quality improvement initiatives including the redesign of the outpatient center focused on streamlining the patient’s experience.

She currently serves as a member of the American Board of Internal Medicine Gastroenterology Board.

Ms. Wingate holds a bachelor's degree in arts, health and society from the University of Rochester, and has completed master’s degree coursework at New York University’s Robert F. Wagner Graduate School for Public Service.

As of January 2020, Ms. Wingate reported the following external relationships:

Service on a research-related expert panel or advisory board for the following companies, with compensation for travel expenses and honoraria:

  • Celgene, for an inflammatory bowel disease research survey, receiving honoraria.
  • Pfizer, ulcerative colitis narrative research study, receiving reimbursement for travel expenses and honoraria.
  • Ms. Wingate serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

    • Crohn's and Colitis Foundation, Senior Vice President of Education, Support, Advocacy, receiving salary support.
    • Food and Drug Institute, Advisor, without compensation.